SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-062840
Filing Date
2022-10-07
Accepted
2022-10-07 17:01:33
Documents
106
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_allaritytherap.htm   iXBRL 10-Q 1154118
2 SEPARATION AGREEMENT WITH STEVE CARCHEDI f10q0622ex10-5_allarity.htm EX-10.5 45593
3 SEPARATION AGREEMENT WITH JENS KNUDSEN f10q0622ex10-6_allarity.htm EX-10.6 42617
4 SECOND AMENDMENT TO DEVELOPMENT, OPTION & LICENSE AGREEMENT f10q0622ex10-7_allarity.htm EX-10.7 12695
5 CERTIFICATION f10q0622ex31-1_allarity.htm EX-31.1 10368
6 CERTIFICATION f10q0622ex31-2_allarity.htm EX-31.2 10463
7 CERTIFICATION f10q0622ex32-1_allarity.htm EX-32.1 4708
8 CERTIFICATION f10q0622ex32-2_allarity.htm EX-32.2 4468
9 GRAPHIC ex10-5_001.jpg GRAPHIC 3689
10 GRAPHIC ex10-6_001.jpg GRAPHIC 3689
  Complete submission text file 0001213900-22-062840.txt   7403856

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE allr-20220630.xsd EX-101.SCH 93782
12 XBRL CALCULATION FILE allr-20220630_cal.xml EX-101.CAL 42494
13 XBRL DEFINITION FILE allr-20220630_def.xml EX-101.DEF 362737
14 XBRL LABEL FILE allr-20220630_lab.xml EX-101.LAB 710670
15 XBRL PRESENTATION FILE allr-20220630_pre.xml EX-101.PRE 386564
100 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_allaritytherap_htm.xml XML 965897
Mailing Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41160 | Film No.: 221301356
SIC: 2834 Pharmaceutical Preparations